Ruth Sweet, CFNP | |
300 S Washington Ave, Greenville, MS 38701-4719 | |
(662) 334-2209 | |
(662) 334-2146 |
Full Name | Ruth Sweet |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Location | 300 S Washington Ave, Greenville, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255429031 | NPI | - | NPPES |
04537077 | Medicaid | MS | |
163535758 | Medicaid | AR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363L00000X | Nurse Practitioner | R620831 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ruth Sweet, CFNP 1693 Fairgrounds Rd, Greenville, MS 38703-7810 Ph: (662) 725-2749 | Ruth Sweet, CFNP 300 S Washington Ave, Greenville, MS 38701-4719 Ph: (662) 334-2209 |
News Archive
Volume 3, Issue 6 of the Global Health Diplomacy Network's "Health Diplomacy Monitor" is now available online.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the presentation of preclinical research describing the mechanism of action of otelixizumab at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD). In addition, Tolerx also announced that the first European patient was enrolled in DEFEND-2, a confirmatory Phase 3 clinical trial evaluating otelixizumab in autoimmune new-onset type 1 diabetes.
Experts in pediatric kidney disease have published a new staging system to help doctors better predict the length of time until a child with chronic kidney disease (CKD) will need to undergo a kidney transplant or start receiving dialysis. Although this type of prognostic guide exists for adults, this is the first such tool specific to children.
(PINKSHEETS: HRAL) HearAtLast Holdings, Inc., a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced today that the Company is in the final development stage of a new Tinnitus Clinic located in the prominent Kingsway Community of Toronto, Ontario Canada.
Data presented today from a pivotal, phase III randomized clinical trial for patients with recurrent glioblastoma tumors suggest that Tumor Treating Fields (TTF) therapy may increase median survival time and improve quality of life scores compared to best standard of care chemotherapy.
› Verified 3 days ago
Mrs. Chasity Ann Sheppeard, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2525 Highway 1 S Ste A, Greenville, MS 38701 Phone: 623-351-1103 Fax: 662-335-8746 | |
James A Ray, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1400 E Union St, Greenville, MS 38703 Phone: 662-378-3783 | |
Ms. Marilyn D Williams, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 129 E Starling St Ste A, Greenville, MS 38701 Phone: 662-378-8868 Fax: 662-378-8462 | |
Mrs. Tammy White Burton, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1462 Highway 1 S, Greenville, MS 38701 Phone: 662-702-5121 | |
Barbara P Adams, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 344 Arnold Ave, Greenville, MS 38701 Phone: 662-344-9100 Fax: 662-344-9120 | |
Marshalvia Bryant, NP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 1221 E Union St, Greenville, MS 38703 Phone: 731-394-1145 | |
Kelli Bearden, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1502 S Colorado St, Greenville, MS 38703 Phone: 662-332-9872 |